Qureight raises €17.6M Series B backed by Ascension VC, Guinness Ventures and more
Qureight closed its Series B funding round on July 29, 2026. The round included six participating investors: Ascension VC, Guinness Ventures, Hargreave Hale AIM VCT, Meltwind, Molten Ventures, and XTX Ventures. The company has raised €7.8M before, making its total funding €25.6M to date.
Based in the United Kingdom, Qureight delivers AI imaging and analytics to accelerate respiratory drug approvals in the pharmaceutical sector. The company operates within healthcare and life sciences and was co-founded by Muhunthan Thillai and Alessandro Ruggiero.
In the past 12 months, Brouky tracked 269 funding deals in healthcare and life sciences in the UK, with a median deal size of €11.2M.
Related insights
- Deal SpotlightDTCP Defence Fund I raises EUR455M Series C+ with Deutsche Telekom, EIFO, Porsche and Smartcap
- Cross-Country AnalysisHealthcare's 2pp funding share decline contrasts with Industry's 1.5pp rise in France and Spain
- Cross-Country AnalysisFinance & Blockchain's 3.9pp seed funding share drop contrasts with AI's smaller 1.3pp decline
- ResearchCzech and Slovak Startup Capital Fell 70% in 2023. Deal Count Fell 22%.
Explore the full dataset
Brouky tracks 36,000+ investors and 100,000+ investments across 84,000+startups. Search by country, stage, and sector.